News: $HEB Hemispherx To Be Transparent on the Development of Ampligen and Announced Significant Progress
NEW YORK, NY / ACCESSWIRE / May 1, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Hemispherx Biopharma, Inc. (NYSE: HEB) , a specialty pharmaceutical company, eng...